Skip to main content

Dr. Selig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Selig's full profile

Already have an account?

Education & Training

  • University of Colorado School of Medicine Anschutz Medical Campus
    University of Colorado School of Medicine Anschutz Medical CampusClass of 2007
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2007 - 2012

Publications & Presentations

PubMed

Press Mentions

  • Immunocore Announces FDA Approval of KIMMTRAK® (Tebentafusp-Tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma
    Immunocore Announces FDA Approval of KIMMTRAK® (Tebentafusp-Tebn) for the Treatment of Unresectable or Metastatic Uveal MelanomaJanuary 27th, 2022
  • Melanoma Research Foundation Launches Historic Patient-Reported Ocular Melanoma Registry
    Melanoma Research Foundation Launches Historic Patient-Reported Ocular Melanoma RegistryMay 10th, 2021